ZBNA
KRYS icon

Zions Bancorporation, National Association’s Krystal Biotech KRYS Stock Holding History

Zions Bancorporation, National Association’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.32K Buy
17
+5
+42% +$1.49K ﹤0.01% 1016
2026
Q1 		$3.1K Buy
+12
New +$3.19K ﹤0.01% 1103

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Zions Bancorporation, National Association's KRYS Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Krystal Biotech (KRYS) stake by 42% in Q2 2026, buying an estimated $1.49K and bringing the position to 17 shares worth $6.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Zions Bancorporation, National Association first reported a position in KRYS in Q1 2026 and has held it in 2 quarters since. 186 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Zions Bancorporation, National Association held 17 shares of Krystal Biotech worth $6.32K as of Q2 2026.
  • Zions Bancorporation, National Association bought 5 Krystal Biotech shares in Q2 2026, an estimated $1.49K.
  • Krystal Biotech made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1016 holding.
  • Zions Bancorporation, National Association first reported a position in Krystal Biotech in Q1 2026 and has held it in 2 quarters since.
  • 186 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.